This thread was suggested by @fireopal and now open for discussion PDUFA dates and FDA Panel Review dates are very important because they are make or break events for biostocks when the decisions are announced. Also, usually biostocks experience a run-up going into the scheduled decision/review dates. So having prior knowledge of the catalysts goes a long way toward maximizing profit or minimizing loss while trading volatile biotech stocks. http://www.rttnews.com/corpinfo/fdacalendar.aspx Listed below are large cap, mid cap and small cap stocks with pending regulatory catalysts.
Have 3 coming up this weekend which i don't like when they do. 9/25 - AMGN - PTIE - DRRX have a couple links too so adding this one which lists a few that i am not seeing @ your link http://biopharmcatalyst.com/calendars/fda-calendar forgot to say thanks here tiptop
not sure but looks like EARS may have some news coming around the end of this month https://clinicaltrials.gov/ct2/show/record/NCT02040194 came close to picking up some when it hit 52 week low but have not pulled trigger yet but watching closely b/c do expect it to get back to normal trading ranges. adding - just cross checked clinical trials with my other link and their top line data is not due until 4Q so may not be any news coming end of this month
I am a little out of my element in biotech stocks but it is time for me to do a little DD before I make the plunge. I haven't bought a biotech since the dot com days. It went to the moon before it crashed and burned Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential AIMT, PCRX, and UTHR http://247wallst.com/healthcare-bus...stocks-to-buy-with-over-100-upside-potential/
I'm sitting on some biotechs. Just Gamble's really. So far I'm up or break even on them. Navb Aezs Dnai Clrb Aezs has phase 3 results coming soon on 2 drugs. Navb owns another company called macrophage therapeutics. They are rumored to have drugs that if approved will be worth billions.
AXON - Axovant Sciences Receives FDA Fast-Track Designation for Intepirdine as an Investigational Treatment for Dementia with Lewy Bodies https://finance.yahoo.com/news/axovant-sciences-receives-fda-fast-120000456.html
Let me add PIP to the mix. Looks promising for under $4 http://stockaholics.net/threads/the-fda-and-the-biotechs.2284/
This was posted by @twerpner on the PIP thread so we already have a red flag "Hey @Tiptopptrader, Ive been watching PIP since November and they have a special dividend getting ready to be paid out. http://www.streetinsider.com/Divide...Declares+$2.91+Special+Dividend/12263431.html I would suggest looking this over before jumping in as this will have a substantial impact on the pps in the next few weeks"
Why Pain Therapeutics, Inc. (PTIE) Shares Jumped 70% Today https://finance.yahoo.com/news/why-pain-therapeutics-inc-ptie-150515646.html
